In all CLL patients with the exception of one, the percentage of IL-17F-expressing CD4+ T cells was higher after in vitro activation in the presence of the Th17-promoting cytokine cocktail, with the positive change between baseline and day 7 being statistically different (p = 0.0010). This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.